The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries
Open accessAbstract
Introduction: Acute stroke unit care, intravenous thrombolysis and endovascular treatment significantly improve the outcome for patients with ischaemic stroke, but data on access and delivery throughout Europe are lacking. We assessed best available data on access and delivery of acute stroke unit care, intravenous thrombolysis and endovascular treatment throughout Europe. Methods: A survey, drafted by stroke professionals (ESO, ESMINT, EAN) and a patient organisation (SAFE), was sent to national stroke societies and experts in 51 European countries (World Health Organization definition) requesting experts to provide national data on stroke unit, intravenous thrombolysis and endovascular treatment rates. We compared both pooled and individual national data per one million inhabitants and per 1000 annual incident ischaemic strokes with highest country rates. Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report. Results: We obtained data from 44 European countries. The estimated mean number of stroke units was 2.9 per million inhabitants (95% CI 2.3–3.6) and 1.5 per 1000 annual incident strokes (95% CI 1.1–1.9), highest country rates were 9.2 and 5.8. Intravenous thrombolysis was provided in 42/44 countries. The estimated mean annual number of intravenous thrombolysis was 142.0 per million inhabitants (95% CI 107.4–176.7) and 72.7 per 1000 annual incident strokes (95% CI 54.2–91.2), highest country rates were 412.2 and 205.5. Endovascular treatment was provided in 40/44 countries. The estimated mean annual number of endovascular treatments was 37.1 per million inhabitants (95% CI 26.7–47.5) and 19.3 per 1000 annual incident strokes (95% CI 13.5–25.1), highest country rates were 111.5 and 55.9. Overall, 7.3% of incident ischaemic stroke patients received intravenous thrombolysis (95% CI 5.4–9.1) and 1.9% received endovascular treatment (95% CI 1.3–2.5), highest country rates were 20.6% and 5.6%. Conclusion: We observed major inequalities in acute stroke treatment between and within 44 European countries. Our data will assist decision makers implementing tailored stroke care programmes for reducing stroke-related morbidity and mortality in Europe.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goyal, M., Menon, B. K., van Zwam, W. H., Dippel, D. W. J., Mitchell, P. J., Demchuk, A. M., Dávalos, A., Majoie, C. B. L. M., van der Lugt, A., de Miquel, M. A., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00163-x · Cited by 7,815
Wang, H., Naghavi, M., Allen, C., Barber, R. M., Bhutta, Z. A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., Coates, M. M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31012-1 · Cited by 6,596
Self-citationFeigin, V. L., Lawes, C. M., Bennett, D. A., Barker-Collo, S. L., & Parag, V. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70025-0 · Cited by 2,855 · cited 1×
“Twenty to 35% of stroke patients die within the first month after a stroke, and up to onethird of survivors lose their independence.(3,4,5) Consequently, the socioeconomic impact of stroke is considerable: the annual cost of stroke in Europe is estimated to be e45 billion: e20 billion for direct care, e9 billion relat…”
BackgroundSelf-citationEmberson, J., Lees, K. R., Lyden, P., Blackwell, L., Albers, G., Bluhmki, E., Brott, T., Cohen, G., Davis, S., Donnan, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60584-5 · Cited by 2,737
Feigin, V. L., Norrving, B., & Mensah, G. A. (2017) · Circulation Research · doi:10.1161/circresaha.116.308413 · Cited by 2,184
Self-citationFeigin, V. L., Roth, G. A., Naghavi, M., Parmar, P., Krishnamurthi, R., Chugh, S., Mensah, G. A., Norrving, B., Shiue, I., Ng, M., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30073-4 · Cited by 1,691 · cited 4×
“Population estimates were based on United Nations data, stroke incidences on the Global Burden of Disease Report.”
MethodInfluentialSelf-citationCardiovascular disease in Europe: epidemiological update 2016
Townsend, N., Wilson, L., Bhatnagar, P., Wickramasinghe, K., Rayner, M., & Nichols, M. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw334 · Cited by 1,579
Stroke incidence and prevalence in Europe: a review of available data
Truelsen, T., Piechowski‐Jóźwiak, B., Bonita, R., Mathers, C., Bogousslavsky, J., & Boysen, G. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01138.x · Cited by 665
Langhorne, P., Williams, B. O., Gilchrist, W., & Howie, K. (1993) · The Lancet · doi:10.1016/0140-6736(93)92813-9 · Cited by 588
European Cardiovascular Disease Statistics 2017
Wilkins, E., Wilson, L. R., Wickramasinghe, K. K., Bhatnagar, P., Leal, J. L., Luengo-Fernández, R., Burns, R., Rayner, M., & Townsend, N. P. (2017) · Bristol Research (University of Bristol) · Cited by 516
Warlow, C., Sudlow, C., Dennis, M., Wardlaw, J., & Sandercock, P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14544-8 · Cited by 378
Wahlgren, N., Moreira, T., Michel, P., Steiner, T., Jansen, O., Cognard, C., Mattle, H. P., van Zwam, W., Holmin, S., Tatlisumak, T., et al. (2016) · International Journal of Stroke · doi:10.1177/1747493015609778 · Cited by 369
Self-citationJørgensen, H. S., Nakayama, H., Raaschou, H. O., Larsen, K., Hübbe, P., & Olsen, T. S. (1995) · Stroke · doi:10.1161/01.str.26.7.1178 · Cited by 297
Stroke Unit Treatment: 10-Year Follow-Up
Indredavik, B., Bakke, F., Slørdahl, S. A., Rokseth, R., & Håheim, L. L. (1999) · Stroke · doi:10.1161/01.str.30.8.1524 · Cited by 263
Helsingborg Declaration 2006 on European Stroke Strategies
Kjellström, T., Norrving, B., & Shatchkute, A. (2007) · Cerebrovascular Diseases · doi:10.1159/000097646 · Cited by 211
Three-month stroke outcome: The European Registers of Stroke (EROS) Investigators
Heuschmann, P. U., Wiedmann, S., Wellwood, I., Rudd, A., Carlo, A. D., Béjot, Y., Ryglewicz, D., Rastenytė, D., & Wolfe, C. D. A. (2010) · Neurology · doi:10.1212/wnl.0b013e318206ca1e · Cited by 156
European Recommendations on Organisation of Interventional Care in Acute Stroke (EROICAS)
Fiehler, J., Cognard, C., Gallitelli, M., Jansen, O., Kobayashi, A., Mattle, H. P., Muir, K. W., Mazighi, M., Schaller, K., & Schellinger, P. D. (2016) · International Journal of Stroke · doi:10.1177/1747493016647735 · Cited by 132
Self-citationEstimating the number of UK stroke patients eligible for endovascular thrombectomy
McMeekin, P. J., White, P., James, M. A., Price, C., Flynn, D., & Ford, G. A. (2017) · European Stroke Journal · doi:10.1177/2396987317733343 · Cited by 130
Stroke Neurologist’s Perspective on the New Endovascular Trials
Grotta, J. C., & Hacke, W. (2015) · Stroke · doi:10.1161/strokeaha.115.008384 · Cited by 128
Acute Stroke Care in Korea in 2013–2014: National Averages and Disparities
Kim, J. Y., Lee, K., Kang, J., Kim, B. J., Kim, S.-E., Oh, H., Park, H., Cho, Y., Park, J., Park, K., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e167 · Cited by 26
McMeekin, P. J., Flynn, D., Allen, M., Coughlan, D., Ford, G. A., Lumley, H., Balami, J. S., James, M. A., Stein, K., Burgess, D., et al. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-4678-9 · Cited by 20
Abilleira, S., de Sousa, D. A., Gattringer, T., Kobayashi, A., Fazekas, F., Szikora, I., Feigin, V. L., Caso, V., Gallofré, M., Fischer, U., et al. (2019) · European Stroke Journal · doi:10.1177/2396987319837106 · Cited by 11
Self-citationIs Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?
Jurjāns, K., Vikmane, B., Vētra, J., Miglāne, E., Kalējs, O., Priede, Z., & Millers, A. (2019) · Medicina · doi:10.3390/medicina55090586 · Cited by 6
The Future of Stroke Interventions
Abergel, E. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10404 · Cited by 6
Cited by
Feigin, V. L., Stark, B. A., Johnson, C. O., Roth, G. A., Bisignano, C., Abady, G. G., Abbasifard, M., Abbasi-Kangevari, M., Abd-Allah, F., Abedi, V., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00252-0 · Cited by 7,937
Self-citationEuropean Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Berge, E., Whiteley, W., Audebert, H., De Marchis, G., Fonseca, A. C., Padiglioni, C., Pérez de la Ossa, N., Strbian, D., Tsivgoulis, G., & Turc, G. (2021) · European Stroke Journal · doi:10.1177/2396987321989865 · Cited by 1,355
Feigin, V. L., Owolabi, M. O., Feigin, V. L., Abd-Allah, F., Akinyemi, R. O., Bhattacharjee, N. V., Brainin, M., Cao, J., Caso, V., Dalton, B., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00277-6 · Cited by 804
Self-citationTurc, G., Bhogal, P., Fischer, U., Khatri, P., Lobotesis, K., Mazighi, M., Schellinger, P. D., Toni, D., de Vries, J., White, P., et al. (2023) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2018-014569 · Cited by 611
Self-citationAction Plan for Stroke in Europe 2018–2030
Norrving, B., Barrick, J., Davalos, A., Dichgans, M., Cordonnier, C., Guekht, A., Kutluk, K., Mikulik, R., Wardlaw, J., Richard, E., et al. (2018) · European Stroke Journal · doi:10.1177/2396987318808719 · Cited by 600
Self-citation
Metadata
- Authors
- Aguiar de Sousa, D., von Martial, R., Abilleira, S., Gattringer, T., Kobayashi, A., Gallofré, M., Fazekas, F., Szikora, I., Feigin, V., Caso, V., Fischer, U., & collaborators, O. B. O. T. E. E. E. S. S. O. S. C.
- Venue
- European Stroke Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-01
- Volume
- 4
- Issue
- 1
- Pages
- 13-28
- ISSN
- 2396-9873 (ISSN-L)
- 2396-9881
- OpenAlex
- W2883861999
- Cited by
- 342
- References
- 24
- FWCI
- 22.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.